Pierre‐Olivier Blotière

The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality

Aurélie Bannay, C. Chaignot, Pierre‐Olivier Blotière et al. · Medical Care · 2015 · 482 citations

Health Professions, Health Sciences, Clinical Classification Systems +16

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists

Géric Maura, Pierre‐Olivier Blotière, Kim Bouillon et al. · Circulation · 2015 · 167 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study

Sarah Tubiana, Pierre‐Olivier Blotière, Bruno Hoen et al. · BMJ · 2017 · 120 citations · Full text

Dentistry, Dental Public Health, Infectious Disease Epidemiology +15

Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs

Pierre‐Olivier Blotière, F. Raguideau, Alain Weill et al. · Neurology · 2019 · 115 citations · Full text

Medicine, Obstetrics, Pharmacology +17

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

Kim Bouillon, Marion Bertrand, Géric Maura et al. · The Lancet Haematology · 2015 · 95 citations

Medicine, Cardiology, Pharmacotherapy +17